Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Crit Care Med. 2018 Sep;46(9):1471–1479. doi: 10.1097/CCM.0000000000003203

Figure 1.

Figure 1

PCA analysis based on the first two components shows clustering of the three study groups based on their difference in metabolic profile (blue = control subjects, red = TBI treated with placebo, green = TBI treated with probenecid+NAC). The diameter of each circle represents the DModX value, which indicates the observed distance of a particular individual to the principal components model. XCMS-online metabolomics platform (Scripps Research Institute, San Diego, CA)